Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,749 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06530992Recruiting
Tucking and semen quality in adult trans women
This study looks at whether tucking affects semen quality in adult transgender women who are about to start or are on hormone therapy. The results could help patients understand how tucking might impact their fertility options.
InnsbruckAges 18–50 - NCT07788456RecruitingPhase 4
Sequential combination therapy for newly diagnosed ITP in adults
This study tests a combination of multiple drugs given in sequence to adults with newly diagnosed immune thrombocytopenia (ITP), a condition of low platelets. The goal is to see if this approach improves platelet counts and is safe.
TianjinAges 18–75 - NCT07787026Recruiting
Fiber supplement study for gut health
This trial is testing the short-term effects of a multi-fiber supplement on gut health. If you are generally healthy and meet the dietary restrictions, you may be able to participate.
Providence, Rhode IslandAges 18 years+ - NCT07789080Recruiting
Exercise program for older women living alone
This study tests a fitness program designed for women aged 75 and older who live alone. The goal is to see if regular exercise can improve their quality of life, independence, and overall well-being.
Oslo, OsloAges 75–100 - NCT07784998Recruiting
Weight-bearing physiotherapy for knee osteoarthritis
This study compares how men and women respond to a special type of physiotherapy that uses gradual weight-bearing exercises to reduce knee pain and improve function. It may help you if you have moderate knee osteoarthritis and are looking for a non-surgical treatment option.
Gujar Khan, Punjab ProvinceAges 40–60 - NCT07786831Recruiting
Dietary study for liver health in young adults
This study tests a 12-week dietary program to see if it can improve liver health in young adults. Participants will be randomly assigned to a specific diet and will attend three check-ups to measure their liver and body changes.
Vienna, AustriaAges 20–30 - NCT07788157Recruiting
Comparing two anesthesia methods for sinus surgery
This study compares two types of anesthesia (one using an injectable drug called fospropofol disodium, and another using inhaled sevoflurane) to see which one provides a better surgical field during endoscopic sinus surgery for chronic rhinosinusitis. If you are scheduled for this surgery and meet the health criteria, you may be able to participate.
Wuhan, HubeiAges 18–65 - NCT07787091RecruitingPhase 1/Phase 2
First study of ARD001 in healthy people and those with hemophilia A
This study tests a new medicine, ARD001, for the first time in humans. It aims to see if the drug is safe and how the body handles it, and it is also being studied in people with hemophilia A to find a safe dose for future trials.
SingaporeAges 21–45 - NCT07784725RecruitingPhase 3
Study of a weight loss injection for adults with obesity
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
Dothan, AlabamaAges 18 years+ - NCT07784270RecruitingPhase 3
Weight loss injection for adults with type 2 diabetes and overweight
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Fairhope, AlabamaAges 18 years+ - NCT07790237Recruiting
Daily supplement for reducing facial wrinkles and improving skin radiance
This study tests whether a daily oral supplement called Dermial® can reduce signs of skin aging and make skin look more radiant. If you're a woman aged 35-65 with visible wrinkles and you're happy to keep your usual skincare routine for about 3 months, you might be a good fit.
Madrid, MadridAges 35–65 - NCT07787130Recruiting
Testing a supplement for preventing colds
This trial tests whether a daily supplement called Immune X can help prevent colds in healthy adults. If you often get colds and are in good health, you might be able to join.
Dijon, Côte-d'OrAges 18–65 - NCT07791043RecruitingPhase 2
Efimosfermin alfa for alcohol-related liver disease
This study tests an investigational medicine called efimosfermin alfa to see if it is safe and effective for people with liver damage caused by heavy drinking. The medicine is compared to a placebo (a dummy treatment).
Topeka, KansasAges 18–75 - NCT06538974Recruiting
Long-term use of an exoskeleton for leg weakness
This trial tests a walking device called an exoskeleton to help people with leg weakness or movement problems. It's designed to see if using the exoskeleton regularly over time can help improve walking or mobility.
ParisAges 18 years+ - NCT06543888Recruiting
Exoskeleton training for walking and daily tasks in older adults
This study tests whether a passive lower-limb exoskeleton can help older adults walk better and do daily activities more easily. You will wear the device during training sessions to see if it improves your movement and independence.
Taoyuan, GuishanAges 60 years+ - NCT02893462Recruiting
Collecting health and signal data from ICU patients
This trial sets up a way to collect and store physiological readings (like vital-sign data) from adults in the intensive care unit. It aims to improve how doctors understand and monitor critically ill patients over time.
BrestAges 18 years+ - NCT07779252RecruitingPhase 3
Study of a new treatment for frown lines between the eyebrows
This study tests a new medication (IPN10200) to safely reduce moderate to severe frown lines between the eyebrows in adults. It may help if you are bothered by these lines and are looking for a non-surgical option.
Guangzhou, GuangdongAges 18 years+ - NCT07776210RecruitingPhase 3
Eye drops for chronic dry eye after stem cell transplant
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
Beverly Hills, CaliforniaAges 18 years+ - NCT07782827RecruitingPhase 3
Angel syndrome treatment study for children and adults
This study tests an experimental medicine for Angelman syndrome (AS), a genetic condition affecting the nervous system. The medicine is given by lumbar puncture and aims to improve symptoms.
Carrboro, North CarolinaAges 2–50 - NCT07776509RecruitingPhase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Escondido, CaliforniaAges 18 years+ - NCT07783802RecruitingPhase 2
Study of clazakizumab for adults with high inflammation and heart risk
This study tests whether clazakizumab can reduce the risk of heart attacks or strokes in people with high levels of inflammation (measured by a blood test called hsCRP) and conditions like heart disease, obesity, diabetes, high blood pressure, or kidney disease. If you qualify, you'll receive either the study drug or a placebo to see if it helps lower your risk.
Huntsville, AlabamaAges 18 years+ - NCT07780383RecruitingPhase 1
Single-dose study for healthy adults and early Alzheimer's participants
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
Anaheim, CaliforniaAges 18–80 - NCT07780903Recruiting
Digital program for young adult cancer survivors to learn about healthcare costs
This study tests a digital program to help young adult cancer survivors learn about managing healthcare costs. If you have finished active cancer treatment, you may be able to join.
New York, New YorkAges 18–39 - NCT07777328Recruiting
5-HTP for ADHD traits and eye movements in adults
This study looks at how a supplement called 5-HTP (a natural amino acid) affects attention and eye movements in adults. You will receive either 5-HTP or a placebo to see if it changes ADHD-like traits.
Sheffield, South YorkshireAges 18–65
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,749 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.